At Ozlem Healthcare, we are dedicated to delivering high-quality pharmaceutical formulations across critical therapeutic segments. Our diverse portfolio includes general medicine, anti-infectives, nephrology, transplant care, and hospital-focused injectables. We emphasize clinical efficacy, safety, and patient-centric outcomes in every formulation we develop. By addressing chronic kidney disease, acute health conditions, and critical deficiencies, Ozlem Healthcare supports comprehensive disease management, recovery, and long-term improvement in patient quality of life.
Our product range delivers clinically trusted formulations across general medicine, renal care, transplant support, and critical injectables.

(Tacrolimus 0.25 mg)

(Tacrolimus 0.5 mg)

(Tacrolimus 1 mg)

(Tacrolimus 2 mg)

(Alpha Ketoanalogue Tablets)